Patents by Inventor Hyun Jhung Jhun

Hyun Jhung Jhun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising Molokhia extract as active ingredient for improving gut microbiome or for alleviating, preventing, or treating intestinal inflammation, leaky gut syndrome, obesity, or metabolic disease
    Patent number: 12076356
    Abstract: The present invention relates to a prebiotic composition, a composition for improving gut microorganisms, a composition for improving gut health or gut function, a composition for alleviating, preventing, or treating inflammatory bowel disease or leaky gut syndrome, or a composition for alleviating, preventing, or treating obesity or metabolic disease, which each comprise a molokhia extract or a molokhia polymer fraction as an active ingredient to induce the proliferation of beneficial intestinal bacteria and to improve, prevent, or treat gut heath or gut function. In addition, the composition comprising a molokhia extract or a molokhia polymer fraction as an active ingredient can alleviate, prevent, or treat bowel disease or leaky gut syndrome.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: September 3, 2024
    Assignee: KOREA FOOD RESEARCH INSTITUTE
    Inventors: Ho-Young Park, Yoon-sook Kim, Young-do Nam, Moon Ho Do, Mi-Jin Oh, Sang-hoon Lee, Eun Jung Lee, Hye-Bin Lee, Hyun Jhung Jhun
  • COMPOSITION COMPRISING MOLOKHIA EXTRACT AS ACTIVE INGREDIENT FOR IMPROVING GUT MICROBIOME OR FOR ALLEVIATING, PREVENTING, OR TREATING INTESTINAL INFLAMMATION, LEAKY GUT SYNDROME, OBESITY, OR METABOLIC DISEASE
    Publication number: 20210353697
    Abstract: The present invention relates to a prebiotic composition, a composition for improving gut microorganisms, a composition for improving gut health or gut function, a composition for alleviating, preventing, or treating inflammatory bowel disease or leaky gut syndrome, or a composition for alleviating, preventing, or treating obesity or metabolic disease, which each comprise a molokhia extract or a molokhia polymer fraction as an active ingredient to induce the proliferation of beneficial intestinal bacteria and to improve, prevent, or treat gut heath or gut function. In addition, the composition comprising a molokhia extract or a molokhia polymer fraction as an active ingredient can alleviate, prevent, or treat bowel disease or leaky gut syndrome.
    Type: Application
    Filed: September 19, 2019
    Publication date: November 18, 2021
    Applicant: KOREA FOOD RESEARCH INSTITUTE
    Inventors: Ho-Young PARK, Yoon-sook KIM, Young-do NAM, Moon Ho DO, Mi-Jin OH, Sang-hoon LEE, Eun Jung LEE, Hye-Bin LEE, Hyun Jhung JHUN
  • Use of proinsulin for immune system modulation
    Patent number: 9669073
    Abstract: The present disclosure relates to a composition for promoting immune activity including a protein selected from the group consisting of dimeric proinsulin, C-peptide partially deleted mutant of dimeric proinsulin, and C-peptide partially deleted mutant of monomeric proinsulin as an effective component and a composition for immunosuppression including C-peptide site of proinsulin as an effective component, and the dimeric proinsulin, the C-peptide partially deleted mutant of dimeric proinsulin, and the C-peptide partially deleted mutant of monomeric proinsulin can be applied as immune enhancers to diabetic patients.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: June 6, 2017
    Assignee: Konkuk University Industrial Cooperation Corporation
    Inventors: Soohyun Kim, Si-Young Lee, Eunsom Kim, Seunghyun Jo, Youngmin Lee, Tania Azam, Suyoung Bae, Areum Kwak, Jaewoo Hong, Hyun Jhung Jhun, Jong Ho Lee, Jungmin Lee, Sulah Youn, Busun Kim
  • USE OF PROINSULIN FOR IMMUNE SYSTEM MODULATION
    Publication number: 20160184402
    Abstract: The present disclosure relates to a composition for promoting immune activity including a protein selected from the group consisting of dimeric proinsulin, C-peptide partially deleted mutant of dimeric proinsulin, and C-peptide partially deleted mutant of monomeric proinsulin as an effective component and a composition for immunosuppression including C-peptide site of proinsulin as an effective component, and the dimeric proinsulin, the C-peptide partially deleted mutant of dimeric proinsulin, and the C-peptide partially deleted mutant of monomeric proinsulin can be applied as immune enhancers to diabetic patients.
    Type: Application
    Filed: March 31, 2015
    Publication date: June 30, 2016
    Inventors: Soohyun Kim, Si-Young Lee, Eunsom Kim, Seunghyun Jo, Youngmin Lee, Tania Azam, Suyoung Bae, Areum Kwak, Jaewoo Hong, Hyun Jhung Jhun, Jong Ho Lee, Jungmin Lee, Sulah Youn, Busun Kim